Skip to main content
. 2015 Mar 19;10(3):e0120794. doi: 10.1371/journal.pone.0120794

Table 3. Serum miRNA expression levels in CHC patients and healthy controls.

miRNA CHC patients (n = 106) Controls (n = 40) P value
miR-146a 2.75 (1.07–13.62) 5.77 (5.14–22.75) 0.011*
miR-34a 3.54 (1.71–7.3) 0.61 (0.28–0.78) <0.0001*
miR-130a 3.41 (1.73–10.7) 1.01 (0.12–1.03) <0.0001*
miR-19a 6.28 (2.29–20.12) 1.36 (0.91–2.03) <0.0001*
miR-192 1.91 (0.82–3.6) 0.64 (0.05–0.86) <0.0001*
miR-195 21.56 (8.75–53.1) 9.8 (4.8–19.3) 0.0002*
miR-296 2.2 (0.89–3.82) 0.4 (0.2–0.62) <0.0001*

Data are expressed as median (25%-75% percentiles) and were analyzed by Mann-Whitney U test.

* indicates statistical significance (P<0.05).